Liofen XL 20 Capsule contains Baclofen 20 mg, a centrally acting skeletal muscle relaxant primarily indicated for the management of spasticity associated with multiple sclerosis, spinal cord injuries, and other neurological disorders. Baclofen exerts its therapeutic effect by activating GABA-B receptors in the central nervous system, leading to inhibition of monosynaptic and polysynaptic reflexes at the spinal level, thereby reducing muscle spasticity and associated pain. Liofen XL is formulated as an extended-release capsule to provide a sustained therapeutic effect, improving patient compliance by reducing dosing frequency. It is typically administered orally, with dosage individualized based on clinical response and tolerability. Common side effects include drowsiness, dizziness, weakness, and gastrointestinal disturbances, which generally diminish with continued use. Caution is advised when prescribing Liofen XL to patients with renal impairment, epilepsy, or a history of hypersensitivity to Baclofen. Abrupt discontinuation should be avoided to prevent withdrawal symptoms such as hallucinations, seizures, or rebound spasticity. Liofen XL 20 Capsule should be used under strict medical supervision, with regular monitoring to optimize therapeutic outcomes and minimize adverse effects. It is contraindicated in patients with hypersensitivity to Baclofen or any capsule excipients.